ํ—ˆ์•ฝ / Frailty

์ •์˜

Frailty๋Š” ๊ณ ๋ น ์‘๊ธ‰ํ™˜์ž์˜ ์ƒ๋ฆฌ์  ์˜ˆ๋น„๋ ฅ ์ €ํ•˜์™€ ์ทจ์•ฝ์„ฑ์„ ๋ฐ˜์˜ํ•˜๋Š” ์ž„์ƒ ์ƒํƒœ์ด๋‹ค.

์ž„์ƒ ํ•ต์‹ฌ

์‘๊ธ‰์‹ค์—์„œ ICU admission, mortality, 72h revisit, functional decline ์˜ˆ์ธก๊ณผ ์—ฐ๊ฒฐ๋  ์ˆ˜ ์žˆ๋‹ค. ๋…ธ์ธ์‘๊ธ‰์˜ ์žฅ๊ธฐ ์—ฐ๊ตฌ ์ถ•์œผ๋กœ ์ ํ•ฉํ•˜๋ฉฐ ๊ฐ์—ผ, ์‹ค์‹ , ๋ณตํ†ต, ํ‡ด์› ์‹คํŒจ์™€ ํ•จ๊ป˜ ๋‹ค๋ฃฐ ์ˆ˜ ์žˆ๋‹ค. Frailty ๊ธฐ๋ฐ˜ ED disposition tool ๊ฐœ๋ฐœ์ด ๊ฐ€๋Šฅํ•œ ์ฃผ์ œ๋‹ค.

์ง„๋‹จ

์‘๊ธ‰์‹ค frailty screening์„ ์‹ค์ œ workflow์— ๋„ฃ๊ณ  outcome๊ณผ ์—ฐ๊ณ„ํ•ด ํ‰๊ฐ€ํ•œ๋‹ค. Lactate, qSOFA, NEWS2 ๊ฐ™์€ sepsis marker ๋˜๋Š” risk score์˜ ์„ฑ๋Šฅ์ด frailty์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์ง€๋Š”์ง€ ๊ฒ€์ฆํ•  ์ˆ˜ ์žˆ๋‹ค.

์น˜๋ฃŒ

Frailty ์ž์ฒด์˜ ์‘๊ธ‰ ์น˜๋ฃŒ๋ณด๋‹ค disposition, ์ถ”์ , ๊ธฐ๋Šฅ outcome ํ‰๊ฐ€๊ฐ€ ์ค‘์š”ํ•˜๋‹ค. Screening pathway ๊ฐœ์ž…์œผ๋กœ ํ‡ด์› ์‹คํŒจ๋‚˜ ์žฌ๋ฐฉ๋ฌธ ๊ฐ์†Œ ์—ฌ๋ถ€๋ฅผ ๋ณผ ์ˆ˜ ์žˆ๋‹ค.

์ถœ์ฒ˜

ACEP geriatric ED guideline; SAEM geriatric EM ์ž๋ฃŒ.

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.